Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Risperidone Augmentation in Patients With Schizophrenia

This study has been completed.
Stanley Medical Research Institute
Information provided by (Responsible Party):
Oliver Freudenreich, Massachusetts General Hospital Identifier:
First received: February 8, 2006
Last updated: October 29, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: March 2007
  Primary Completion Date: March 2007 (Final data collection date for primary outcome measure)